LIVE 11/3/2015 2:45PM @The 15th Annual EmTech MIT – MIT Media Lab: Top 10 Breakthrough Technologies & 2015 Innovators Under 35
|
Live Press Coverage in REAL TIME Aviva Lev-Ari, PhD, RN Director & Founder, Leaders in Pharmaceutical Business Intelligence, Boston Co-Founder, GDE |
2:45 Start Making More Sense
A discussion surrounding the importance of multidimensional sensing and the relationship between software, algorithms and the sensor ecosystem itself, required for autonomous machines.
Michael Murray
General Manager, Industrial Sensing Group, Analog Devices, Inc.
Presented by Analog Devices
WAS COVERED IN PREVIOUS TALK From 1:30PM
3:00 Investing in Big Ideas
Insights into investing in big ideas, from a thought leader in the VC industry and board member of companies including Tesla and SpaceX.
Steve Jurvetson
Partner, DFJ
Investing in Big Ideas
Jason: Four Investments
Steve:
- Telsa as an investment – Mask Effect is Huge – ambition to go to Mars
- Nervana -chip company, custom chip as cloud algorithms
- Blood Kit and FDA investment of $100,000 Sample collection – visible in Life Sciences
3:30 Break & Networking
4:00 Meet the Innovators Under 35
Travis Deyle
Senior Hardware Engineer, Google
2015 Innovator Under 35
- Lifestyle Devices
- Medical Devices
- Healthcare Robots: Right Medications to Right Person at right Time
Jeannette Garcia
Research Staff Member, IBM
2015 Innovator Under 35
- Polymers – not all melt, save on landfill space
- Industrial polymers – revert back to powder
- Computational Chemistry and 3D Printing: New materials recycled
Jamie Shotton
Principal Researcher, Microsoft Research
2015 Innovator Under 35
- building mathematical models to capture Human face
- human hand: rotate – hand schleton
Lars Blackmoore
- DroneShip for a drone landing @MIT
4:15 Virtual Reality
The way that we engage with our connected environments is evolving radically. How will the growing use of virtual reality solutions intersect with expectations for augmented capabilities in the real world?
Mary Lou Jepsen
Executive Director of Engineering, Facebook, Head of Display Technologies, Oculus
Virtual Reality
Jason: Laptop for every Child in the World – Laptop price went down, Consumer electronics Ministry of Education attention, Thailand are buying tablets cheaper than Books, China and India, Peru had th elaptop.
- Strechable screen
- Screen Technology – virtual reality – rethink the screen
- Facebook – create new kind of Interface: Content Piece, interaction of hardware,
- Virtual Reality – stereoscopic vision for Virtual Reality
- Killer up is presence – People are Presence
- Scale screens requires access to big fabrication
- Oculus uses off the shelve parts, Fab can used off the shelves
- Vision on Screen technology Originated in a hologram design at age 18
- Games and movies are 3D already
- Brain augmented Control with EEG
4:45 Innovators Under 35
A look back at 15 years of celebrating MIT Technology Review’s Innovators Under 35.
Jason Pontin
Editor in Chief and Publisher, MIT Technology Review
Kathleen Kennedy
President, MIT Technology Review
5:00 Closing Remarks
5:15Reception
A Celebration of the 2015 Innovators Under 35
Please see the following Meeting @techreview @Jason_Pontit and #EmTechMIT on Twitter and follow us at @pharma_BI
General meeting @
@EmTechMIT (note this is general meeting @)
@MIT
@Pharma_BI
@Boston
@TechHubBoston
@Wired
@techinboston
General meeting #
#EmTechMIT (Note this is the Meeting Hashtag)
#medialab
#TechnologySpotlight
#tech
#startup
#innovation
Please see the Following Talk Specific @ and #
Talk Time @ #
| Start Making More Sense | Nov 3 2:45 PM | @ADI_News
|
#sensor
#software #computing #machinelearning |
| Investing in Big Ideas | Nov 3 3:00 PM | @elonmusk
|
#VC
#investing #startup #innovation |
| Meet the Innovators Under 35 | Nov3 2:30 PM | @MIT
|
#EmTechMIT
|
| Virtual Reality | Nov 3 4:15 PM | @mljmljmlj | #virtualreality
#investing #VC |
2012pharmaceutical
Amandeep Kaur
Aashir Awan, Phd
Adina Hazan
Alan F. Kaul, PharmD., MS, MBA, FCCP
alexcrystal6
anamikasarkar
apreconasia
aviralvatsa
David Orchard-Webb, PhD
danutdaagmailcom
Demet Sag, Ph.D., CRA, GCP
Dror Nir
dsmolyar
Ethan Coomber
evelinacohn
Gail S Thornton
Irina Robu
jayzmit48
jdpmd
jshertok
kellyperlman
Ed Kislauskis
larryhbern
Madison Davis
marzankhan
megbaker58
ofermar2020
Dr. Pati
pkandala
Rosalind Codrington, PhD
ritusaxena
Rick Mandahl
satwik Sunnam
sjwilliamspa
stuartlpbi
Dr. Sudipta Saha
tildabarliya
vaishnavee24
zraviv06
zs22
This is very insightful. There is no doubt that there is the bias you refer to. 42 years ago, when I was postdocing in biochemistry/enzymology before completing my residency in pathology, I knew that there were very influential mambers of the faculty, who also had large programs, and attracted exceptional students. My mentor, it was said (although he was a great writer), could draft a project on toilet paper and call the NIH. It can’t be true, but it was a time in our history preceding a great explosion. It is bizarre for me to read now about eNOS and iNOS, and about CaMKII-á, â, ã, ä – isoenzymes. They were overlooked during the search for the genome, so intermediary metabolism took a back seat. But the work on protein conformation, and on the mechanism of action of enzymes and ligand and coenzyme was just out there, and became more important with the research on signaling pathways. The work on the mechanism of pyridine nucleotide isoenzymes preceded the work by Burton Sobel on the MB isoenzyme in heart. The Vietnam War cut into the funding, and it has actually declined linearly since.
A few years later, I was an Associate Professor at a new Medical School and I submitted a proposal that was reviewed by the Chairman of Pharmacology, who was a former Director of NSF. He thought it was good enough. I was a pathologist and it went to a Biochemistry Review Committee. It was approved, but not funded. The verdict was that I would not be able to carry out the studies needed, and they would have approached it differently. A thousand young investigators are out there now with similar letters. I was told that the Department Chairmen have to build up their faculty. It’s harder now than then. So I filed for and received 3 patents based on my work at the suggestion of my brother-in-law. When I took it to Boehringer-Mannheim, they were actually clueless.